Verrica Pharmaceuticals Inc

NASDAQ:VRCA   3:59:54 PM EDT
9.38
+0.19 (+2.07%)
Earnings Announcements

Verrica Pharmaceuticals Reports Third Quarter 2021 Financial Results

Published: 11/12/2021 12:47 GMT
Verrica Pharmaceuticals Inc (VRCA) - Verrica Pharmaceuticals Reports Third Quarter 2021 Financial Results.
Qtrly GAAP Loss per Share $0.47.
Qtrly Non GAAP Loss per Share $0.40.
Q3 Earnings per Share View $-0.51 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.53

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.